Yahoo
Toronto - Delayed Quote CAD

TelyRx Holdings Inc. (TELY.TO)

2.4000 -0.1000 (-4.00%)
At close: October 30 at 1:58:00 PM EDT
Chart Range Bar
Loading chart for TELY.TO
  • Previous Close 2.5000
  • Open 2.5400
  • Bid 2.3600 x --
  • Ask 2.4500 x --
  • Day's Range 2.4000 - 2.5400
  • 52 Week Range 2.0000 - 4.2500
  • Volume 1,600
  • Avg. Volume 21,143
  • Market Cap (intraday) 63.817M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -0.6900
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est 6.00

TelyRx Holdings Inc. operates as a vertically integrated technology-enabled healthcare and pharmacy services company which develops and operates a digital pharmacy platform. Its platform connects patients nationwide with physicians for access to everyday prescriptions. The company also operates pharmacies which ship the medicine to the patient's door with next-day delivery. It caters to doctors, veterinarians, practice groups, and other licensed prescribers. The company is based in Clearwater, Florida.

TelyRx.com

--

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

TELY.TO
41.46%
S&P/TSX Composite index (^GSPTSE)
11.78%

1-Year Return

TELY.TO
41.46%
S&P/TSX Composite index (^GSPTSE)
18.03%

3-Year Return

TELY.TO
41.46%
S&P/TSX Composite index (^GSPTSE)
88.90%

5-Year Return

TELY.TO
41.46%
S&P/TSX Composite index (^GSPTSE)
69.32%

Earnings Trends

View More

Earnings Per Share (Normalized)

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 22.67M
Earnings --
Profit Margin 0.00%

Q2

FY26

0
5M
10M
15M
20M
0.0%

Analyst Insights

View More

Analyst Price Targets

6.00
6.00 Average
2.4000 Current
6.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -19.36%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    68.72M

  • Net Income Avi to Common (ttm)

    -13.3M

  • Diluted EPS (ttm)

    -0.6900

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    21.68M

  • Total Debt/Equity (mrq)

    123.64%

  • Levered Free Cash Flow (ttm)

    --

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: